UPDF AI

Changes in cholinergic and glutamatergic markers in the striatum from a sub-set of subjects with schizophrenia.

B. Dean,N. Thomas,2 Authors,E. Scarr

2015 · DOI: 10.1016/j.schres.2015.10.028
Schizophrenia Research · 19 Citations

TLDR

The data suggest muscarinic M1 and M2 and/or M4 receptors are lower in the striatum from MRDS which could mediate inappropriate adaption to internal and external cues which, in turn, would affect motivation, cognition and motor control.